Literature DB >> 18810760

Nuclear receptor profile in calvarial bone cells undergoing osteogenic versus adipogenic differentiation.

Flavia Q Pirih1, Rosette Abayahoudian, David Elashoff, Farhad Parhami, Jeanne M Nervina, Sotirios Tetradis.   

Abstract

Nuclear receptors (NRs) are key regulators of cell function and differentiation. We examined NR expression during osteogenic versus adipogenic differentiation of primary mouse calvarial osteoblasts (MOBs). MOBs were cultured for 21 days in osteogenic or adipogenic differentiation media. von Kossa and Oil Red O staining, and qRT-PCR of marker genes and 49 NRs were performed. PCR amplicons were subcloned to establish correct sequences and absolute standard curves. Forty-three NRs were detected at days 0-21. Uncentered average linkage hierarchical clustering identified four expression clusters: NRs (1) upregulated during osteogenic, but not adipogenic, differentiation, (2) upregulated in both conditions, with greater upregulation during adipogenic differentiation, (3) upregulated equally in both conditions, (4) downregulated during adipogenic, but not osteogenic, differentiation. One-way ANOVA with contrast revealed 20 NRs upregulated during osteogenic differentiation and 12 NRs upregulated during adipogenic differentiation. Two-way ANOVA demonstrated that 18 NRs were higher in osteogenic media, while 9 NRs were higher in adipogenic media. The time effect revealed 16 upregulated NRs. The interaction of condition with time revealed 6 NRs with higher expression rate during adipogenic differentiation and 3 NRs with higher expression rate during osteogenic differentiation. Relative NR abundance at days 0 and 21 were ranked. Basal ranking changed at least 5 positions for 13 NRs in osteogenic media and 9 NRs in adipogenic media. Osteogenic and adipogenic differentiation significantly altered NR expression in MOBs. These differences offer a fingerprint of cellular commitment and may provide clues to the underlying mechanisms of osteogenic versus adipogenic differentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18810760      PMCID: PMC5391254          DOI: 10.1002/jcb.21931

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  83 in total

Review 1.  The nuclear receptor superfamily.

Authors:  Marc Robinson-Rechavi; Hector Escriva Garcia; Vincent Laudet
Journal:  J Cell Sci       Date:  2003-02-15       Impact factor: 5.285

Review 2.  International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors.

Authors:  Frédéric Flamant; John D Baxter; Douglas Forrest; Samuel Refetoff; Herbert Samuels; Tom S Scanlan; Bjorn Vennström; Jacques Samarut
Journal:  Pharmacol Rev       Date:  2006-12       Impact factor: 25.468

Review 3.  Playing with bone and fat.

Authors:  Jeffrey M Gimble; Sanjin Zvonic; Z Elizabeth Floyd; Moustapha Kassem; Mark E Nuttall
Journal:  J Cell Biochem       Date:  2006-05-15       Impact factor: 4.429

4.  Effect of age on progesterone receptor expression, and osteoprogenitor proliferation and differentiation in female rat vertebral cell populations.

Authors:  Weidong Pei; Carlton G Bellows; Yongheng Jia; Johan N M Heersche
Journal:  J Endocrinol       Date:  2006-08       Impact factor: 4.286

5.  Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.

Authors:  Rex C Haydon; Lan Zhou; Tao Feng; Benjamin Breyer; Hongwei Cheng; Wei Jiang; Akira Ishikawa; Terrance Peabody; Anthony Montag; Michael A Simon; Tong-Chuan He
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

6.  Functional role of RXRs and PPARgamma in mature adipocytes.

Authors:  D Metzger; T Imai; M Jiang; R Takukawa; B Desvergne; W Wahli; P Chambon
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2005-07       Impact factor: 4.006

7.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

8.  MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors.

Authors:  Su-Li Cheng; Jian-Su Shao; Nichole Charlton-Kachigian; Arleen P Loewy; Dwight A Towler
Journal:  J Biol Chem       Date:  2003-08-18       Impact factor: 5.157

9.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.

Authors:  S S Lee; T Pineau; J Drago; E J Lee; J W Owens; D L Kroetz; P M Fernandez-Salguero; H Westphal; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

10.  Expression of the CD36 homolog (FAT) in fibroblast cells: effects on fatty acid transport.

Authors:  A Ibrahimi; Z Sfeir; H Magharaie; E Z Amri; P Grimaldi; N A Abumrad
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

View more
  5 in total

1.  Osteogenic potential of mandibular vs. long-bone marrow stromal cells.

Authors:  T L Aghaloo; T Chaichanasakul; O Bezouglaia; B Kang; R Franco; S M Dry; E Atti; S Tetradis
Journal:  J Dent Res       Date:  2010-09-01       Impact factor: 6.116

Review 2.  The multi-faceted role of retinoid X receptor in bone remodeling.

Authors:  María P Menéndez-Gutiérrez; Mercedes Ricote
Journal:  Cell Mol Life Sci       Date:  2017-01-19       Impact factor: 9.261

Review 3.  Discovery-driven research and bioinformatics in nuclear receptor and coregulator signaling.

Authors:  Neil J McKenna
Journal:  Biochim Biophys Acta       Date:  2010-10-26

4.  ERRγ is not required for skeletal development but is a RUNX2-dependent negative regulator of postnatal bone formation in male mice.

Authors:  Marco Cardelli; Jane E Aubin
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

5.  Deletion of Orai1 leads to bone loss aggravated with aging and impairs function of osteoblast lineage cells.

Authors:  Hyewon Choi; Sonal Srikanth; Elisa Atti; Flavia Q Pirih; Jeanne M Nervina; Yousang Gwack; Sotirios Tetradis
Journal:  Bone Rep       Date:  2018-04-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.